Rhenman & Partners Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Rhenman & Partners Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-280,000	Closed	-$6.66M	–	97
2023 Q1	$6.66M	Sell	280,000 -150,000	-35%	-$3.28M	0.73%	47
2022 Q4	$9.21M	Buy	430,000 +65,000	+18%	+$1.39M	0.96%	40
2022 Q3	$8.73M	Buy	365,000 +115,000	+46%	+$1.51M	0.91%	42
2022 Q2	$2.4M	Sell	250,000 -10,000	-4%	-$126K	0.27%	75
2022 Q1	$4.38M	Sell	260,000 -90,000	-26%	-$1.33M	0.43%	67
2021 Q4	$5.75M	Hold	350,000	–	–	0.38%	66
2021 Q3	$5.68M	Buy	+350,000	New	+$3.81M	0.4%	68
2017 Q3	–	Sell	-23,920	Closed	-$61K	–	111
2017 Q2	$61K	Hold	23,920	–	–	0.01%	107
2017 Q1	$88K	Hold	23,920	–	–	0.01%	103
2016 Q4	$116K	Buy	+23,920	New	+$710K	0.02%	107

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Rhenman & Partners Asset Management's ISEE Position: Q2 2023 in Review

Rhenman & Partners Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 280,000 shares — an estimated $6.66M sold.

Rhenman & Partners Asset Management first reported a position in ISEE in Q4 2016 and held it in 10 quarters. The position peaked at $9.21M in Q4 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Rhenman & Partners Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Rhenman & Partners Asset Management sold 280,000 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $6.66M.
Rhenman & Partners Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 10 quarters.
Rhenman & Partners Asset Management's IVERIC bio, Inc. Common Stock position peaked at $9.21M in Q4 2022.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.